Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • DoctorDNA
    Junior Member
    • Nov 2011
    • 2

    #1

    Existence Genetics - analysis & reporting of close to 1,500 phenotypes and growing

    Hello community! Wanted to introduce our company, Existence Genetics, which specializes in clinical interpretation and straightforward, actionable reporting of genetic data. Using a proprietary DNA chip manufactured by Illumina, we currently test for, analyze, and provide reporting for around 1,500 phenotypes at a single time via a noninvasive (saliva-based) test. In addition to a comprehensive analysis of multifactorial phenotypes that provides a single lifetime risk calculation for each phenotype, we also provide a rare disease screen that assesses carrier/affected status of over 1,000 rare diseases, conditions, and traits (analyzing over 1,000 genes at a single time!). We utilize our Nexus technology platform, including Reflex analysis, to provide useful information to healthcare providers and their patients throughout the world.

    We look forward to being active participants of this community! We're always happy to meet new people in the sequencing community so please drop us a line if you'd like to talk further.

    We look forward to meeting you!
    Brandon Colby, MD
    Last edited by DoctorDNA; 11-21-2011, 04:44 PM.
  • ECO
    --Site Admin--
    • Oct 2007
    • 1360

    #2
    Hey Brandon, welcome!

    Moving this to Vendor Forum, where this type of content belongs!

    Comment

    • DoctorDNA
      Junior Member
      • Nov 2011
      • 2

      #3
      Originally posted by ECO View Post
      Hey Brandon, welcome!

      Moving this to Vendor Forum, where this type of content belongs!
      Thanks ECO! As we focus on personalized genomics and predictive medicine thought it made sense to say hello in that forum but appreciate you moving us to the most appropriate locale.

      Saw your in the Bay Area - if you're ever down in LA, stop by and say hello as it would be great to meet you in person.

      Comment

      • ECO
        --Site Admin--
        • Oct 2007
        • 1360

        #4
        Would love to...I have family in LA so am down there often! Good luck!

        Comment

        Latest Articles

        Collapse

        • SEQadmin2
          Beyond CRISPR/Cas9: Understand, Choose, and Use the Right Genome Editing Tool
          by SEQadmin2



          CRISPR/Cas9 sparked the gene editing revolution for both research and therapeutics.1 But this system still showed severe issues that limited its applications. The most prominent were the heavy reliance on PAM sequences, delivery limitations, double-stranded breaks that prompt unintended edits and cell death, and editing inefficiency (both in targeting and in knock-in reliability).

          Despite this, “CRISPR helped turn genome editing from a specialized technique into
          ...
          07-31-2026, 11:01 AM
        • SEQadmin2
          Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
          by SEQadmin2


          Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

          The systematic characterization of the human proteome has
          ...
          07-20-2026, 11:48 AM
        • SEQadmin2
          Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
          by SEQadmin2



          Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
          ...
          07-09-2026, 11:10 AM

        ad_right_rmr

        Collapse

        News

        Collapse

        Topics Statistics Last Post
        Started by SEQadmin2, Today, 10:13 AM
        0 responses
        13 views
        0 reactions
        Last Post SEQadmin2  
        Started by SEQadmin2, 07-31-2026, 02:55 AM
        0 responses
        23 views
        0 reactions
        Last Post SEQadmin2  
        Started by SEQadmin2, 07-24-2026, 12:17 PM
        0 responses
        19 views
        0 reactions
        Last Post SEQadmin2  
        Started by SEQadmin2, 07-23-2026, 11:41 AM
        0 responses
        18 views
        0 reactions
        Last Post SEQadmin2  
        Working...